Laboratoires ISOCELL

Laboratoires ISOCELL is a French biotechnology company specializing in the research and development of antioxidant-based solutions for health and dermatology. The company is best known for developing Gliisodin, the first orally bioavailable form of Superoxide Dismutase (SOD) protected by a wheat protein (gliadin) to prevent degradation in the digestive tract. Their product portfolio focuses on nutricosmetics, skin health, and the management of oxidative stress-related conditions. ISOCELL operates globally, providing patented ingredients and finished products that support immune function, cardiovascular health, and anti-aging. The company's research emphasizes the clinical efficacy of SOD in reducing cellular damage caused by free radicals. Through its proprietary delivery platform, ISOCELL has established itself as a leader in the nutricosmetic industry.